Venus Concept Inc. (VERO)
NASDAQ: VERO · Real-Time Price · USD
2.360
+0.030 (1.29%)
Sep 17, 2025, 4:00 PM EDT - Market closed
Venus Concept Market Cap
Venus Concept has a market cap or net worth of $4.39 million as of September 17, 2025. Its market cap has increased by 9.69% in one year.
Market Cap
4.39M
Enterprise Value
37.57M
1-Year Change
9.69%
Ranking
Category
Stock Price
$2.36
Market Cap Chart
Since October 12, 2017, Venus Concept's market cap has decreased from $278.20M to $4.39M, a decrease of -98.42%. That is a compound annual growth rate of -40.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2025 | 4.30M | 59.26% |
| Dec 31, 2024 | 2.70M | -58.46% |
| Dec 29, 2023 | 6.50M | -69.91% |
| Dec 30, 2022 | 21.60M | -76.55% |
| Dec 31, 2021 | 92.10M | 29.35% |
| Dec 31, 2020 | 71.20M | -48.92% |
| Dec 31, 2019 | 139.40M | 687.57% |
| Dec 31, 2018 | 17.70M | -86.70% |
| Dec 29, 2017 | 133.10M | -52.16% |
| Oct 12, 2017 | 278.20M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 686.51B |
| Johnson & Johnson | 424.98B |
| AbbVie | 382.04B |
| UnitedHealth Group | 307.73B |
| Novo Nordisk | 253.09B |
| AstraZeneca | 240.11B |
| Novartis AG | 237.94B |
| Abbott Laboratories | 231.06B |